BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23635017)

  • 1. Increase in skin autofluorescence and release of heart-type fatty acid binding protein in plasma predicts mortality of hemodialysis patients.
    Arsov S; Trajceska L; van Oeveren W; Smit AJ; Dzekova P; Stegmayr B; Sikole A; Rakhorst G; Graaff R
    Artif Organs; 2013 Jul; 37(7):E114-22. PubMed ID: 23635017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients.
    Meerwaldt R; Hartog JW; Graaff R; Huisman RJ; Links TP; den Hollander NC; Thorpe SR; Baynes JW; Navis G; Gans RO; Smit AJ
    J Am Soc Nephrol; 2005 Dec; 16(12):3687-93. PubMed ID: 16280473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of body mass index on the accumulation of advanced glycation end products in hemodialysis patients.
    Arsov S; Trajceska L; van Oeveren W; Smit AJ; Dzekova P; Stegmayr B; Sikole A; Rakhorst G; Graaff R
    Eur J Clin Nutr; 2015 Mar; 69(3):309-13. PubMed ID: 25585601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin autofluorescence advanced glycosylation end products as an independent predictor of mortality in high flux haemodialysis and haemodialysis patients.
    Nongnuch A; Davenport A
    Nephrology (Carlton); 2015 Nov; 20(11):862-7. PubMed ID: 26014842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
    Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
    Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidized high-density lipoprotein as a risk factor for cardiovascular events in prevalent hemodialysis patients.
    Honda H; Ueda M; Kojima S; Mashiba S; Michihata T; Takahashi K; Shishido K; Akizawa T
    Atherosclerosis; 2012 Feb; 220(2):493-501. PubMed ID: 22119537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of tissue advanced glycation end products correlated with glucose exposure dose and associated with cardiovascular morbidity in patients on peritoneal dialysis.
    Jiang J; Chen P; Chen J; Yu X; Xie D; Mei C; Xiong F; Shi W; Zhou W; Liu X; Sun S; Zhang P; Yang X; Zhang Y; Zhang Y; Liang X; Zhang Z; Lin Q; Yu Y; Miyata T; Tian J; Liang M; Luo W; Xu X; Hou F
    Atherosclerosis; 2012 Sep; 224(1):187-94. PubMed ID: 22857897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin and plasma autofluorescence during hemodialysis: a pilot study.
    Graaff R; Arsov S; Ramsauer B; Koetsier M; Sundvall N; Engels GE; Sikole A; Lundberg L; Rakhorst G; Stegmayr B
    Artif Organs; 2014 Jun; 38(6):515-8. PubMed ID: 24164288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating adipocyte fatty acid-binding protein levels and cardiovascular morbidity and mortality in patients with coronary heart disease: a 10-year prospective study.
    von Eynatten M; Breitling LP; Roos M; Baumann M; Rothenbacher D; Brenner H
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2327-35. PubMed ID: 22679309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin autofluorescence is associated with 5-year mortality and cardiovascular events in patients with peripheral artery disease.
    de Vos LC; Mulder DJ; Smit AJ; Dullaart RP; Kleefstra N; Lijfering WM; Kamphuisen PW; Zeebregts CJ; Lefrandt JD
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):933-8. PubMed ID: 24526694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does hepatitis C increase the accumulation of advanced glycation end products in haemodialysis patients?
    Arsov S; Graaff R; Morariu AM; van Oeveren W; Smit AJ; Busletic I; Trajcevska L; Selim G; Dzekova P; Stegmayr B; Sikole A; Rakhorst G
    Nephrol Dial Transplant; 2010 Mar; 25(3):885-91. PubMed ID: 19934094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoprotegerin and mortality in hemodialysis patients with cardiovascular disease.
    Winther S; Christensen JH; Flyvbjerg A; Schmidt EB; Jørgensen KA; Skou-Jørgensen H; Svensson M
    Clin Nephrol; 2013 Sep; 80(3):161-7. PubMed ID: 23547804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of C-reactive protein and high-sensitivity C-reactive protein levels in patients on hemodialysis.
    Helal I; Zerelli L; Krid M; ElYounsi F; Ben Maiz H; Zouari B; Adelmoula J; Kheder A
    Saudi J Kidney Dis Transpl; 2012 May; 23(3):477-83. PubMed ID: 22569431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased serum carnitine is independently correlated with increased tissue accumulation levels of advanced glycation end products in haemodialysis patients.
    Adachi T; Fukami K; Yamagishi S; Kaida Y; Ando R; Sakai K; Adachi H; Otsuka A; Ueda S; Sugi K; Okuda S
    Nephrology (Carlton); 2012 Nov; 17(8):689-94. PubMed ID: 22804770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EN-RAGE (extracellular newly identified receptor for advanced glycation end-products binding protein) and mortality of long-term hemodialysis patients: A prospective observational cohort study.
    Kalousová M; Kuběna AA; Benáková H; Dusilová-Sulková S; Tesař V; Zima T
    Clin Biochem; 2012 May; 45(7-8):556-60. PubMed ID: 22394461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin autofluorescence is a predictor of cardiovascular disease in chronic kidney disease patients.
    Furuya F; Shimura H; Takahashi K; Akiyama D; Motosugi A; Ikegishi Y; Haraguchi K; Kobayashi T
    Ther Apher Dial; 2015 Feb; 19(1):40-4. PubMed ID: 25545539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients.
    Qureshi AR; Alvestrand A; Divino-Filho JC; Gutierrez A; Heimbürger O; Lindholm B; Bergström J
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S28-36. PubMed ID: 11792759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.
    Panichi V; Rizza GM; Paoletti S; Bigazzi R; Aloisi M; Barsotti G; Rindi P; Donati G; Antonelli A; Panicucci E; Tripepi G; Tetta C; Palla R;
    Nephrol Dial Transplant; 2008 Jul; 23(7):2337-43. PubMed ID: 18305316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of cardiac troponin T and I in hemodialysis patients.
    Kalaji FR; Albitar S
    Saudi J Kidney Dis Transpl; 2012 Sep; 23(5):939-45. PubMed ID: 22982904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ankle-brachial index and cardiovascular mortality in nondiabetic hemodialysis patients.
    Bevc S; Purg D; Turnšek N; Hren M; Hojs N; Zorman T; Pečovnik-Balon B; Dvoršak B; Ekart R; Hojs R
    Ther Apher Dial; 2013 Aug; 17(4):373-7. PubMed ID: 23931874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.